NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/22/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization182.39 mln
Float14.07 mln
Earnings Date08/12/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
6.33
Transformational upside
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
1.40
Elevated leverage
ROE
-612
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Milestone Pharmaceuticals is a Canadian company focused on bringing new heart medications to patients in North America. Its main product, CARDAMYST, is a nasal spray that helps adults quickly restore a normal heart rhythm during episodes of a rapid heartbeat condition known as PSVT. The company is also researching whether the same drug can treat another common heart rhythm disorder called atrial fibrillation, and works with partner Corxel Pharmaceuticals to advance these efforts.
